封面
市场调查报告书
商品编码
1889315

2025年全球可生物降解医用聚合物市场报告

Biodegradable Medical Polymers Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来,可生物降解医用聚合物市场发展迅速,预计将从2024年的23.8亿美元成长到2025年的27.8亿美元,复合年增长率达16.8%。过去几年的成长与以下因素密切相关:监管机构对可生物降解材料的支持力度不断加大、聚合物在药物输送系统中的应用日益广泛、人们越来越重视减少医疗废弃物、对可生物降解聚合物生产的投资不断增加,以及消费者对环保医疗解决方案的需求日益增长。

预计未来几年,可生物降解医用聚合物市场将快速成长,到2029年市场规模将达到51.1亿美元,复合年增长率(CAGR)为16.5%。预测期内的成长预计将受到以下因素的推动:对环保型医疗设备的需求不断增长、聚合物生产商与医疗公司之间的合作日益密切、可生物降解聚合物产能的扩张、天然聚合物在医疗应用中的广泛应用,以及政府对永续医疗材料的激励措施不断增加。预测期内的关键趋势包括:生物聚合物技术的进步、先进药物输送系统的开发、永续医疗设备的创新、天然聚合物共混物的整合以及创伤护理解决方案的改进。

预计未来几年,对微创手术日益增长的需求将推动可生物降解医用聚合物市场的成长。微创手术是一种利用微小切口或非无创技术进行手术的医疗技术,与传统手术相比,可减少组织损伤、加速恢復速度并减轻术后疼痛。此类手术的增加主要归功于医疗技术的进步,这些进步促使精准外科技术在全球范围内广泛应用。可生物降解医用聚合物在支持微创手术方面发挥关键作用,它能够用于开发可在体内自然溶解的临时植入、缝合线和药物传输系统。这减少了二次取出手术的需要,最大限度地减少了组织损伤,并促进了更快的恢復,同时降低了併发症率。例如,2023年2月,总部位于美国的专业组织—美国整形外科医师协会报告称,微创美容手术总数从2022年的2,370万例增加到2023年的2,540万例。这种对微创手术日益增长的需求正在推动可生物降解医用聚合物市场的成长。

生物降解医用聚合物市场的主要企业正致力于生物聚合物技术等创新,以提高医疗设备和药物输送系统的性能、生物相容性和永续性。生物聚合物技术是指使用天然来源的、可生物降解且对环境友善的聚合物。这项技术正被用于开髮用于医疗、包装和工业领域的永续材料,从而减少对合成塑胶的依赖。例如,2023年11月,总部位于瑞士的上市公司苏尔寿宣布推出「CAPSUL」技术,这是一项用于连续生产聚己内酯(PCL,一种可生物降解聚酯)的端到端授权技术。该技术能够以具有竞争力的价格生产高品质的PCL产品,从而支持在医疗和工业应用中使用永续材料,并有助于提高生产效率。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场:宏观经济情景,包括利率、通货膨胀、地缘政治、贸易战和关税,以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球可生物降解医用聚合物市场:PESTEL 分析(政治、社会、技术、环境、法律因素、驱动因素和限制因素)
  • 终端用户产业分析
  • 全球可生物降解医用聚合物市场:成长率分析
  • 全球可生物降解医用聚合物市场表现:规模与成长,2019-2024年
  • 全球可生物降解医用聚合物市场预测:规模与成长,2024-2029年,2034年预测
  • 全球可生物分解医用聚合物市场:潜在市场规模 (TAM)

第六章 市场细分

  • 全球可生物降解医用聚合物市场:依产品类型、性能及预测划分,2019-2024年、2024-2029年预测、2034年预测
  • 聚乳酸
  • 聚乙醇酸
  • 聚己内酯
  • 聚羟基烷酯
  • 其他产品
  • 全球可生物降解医用聚合物市场:依材料种类、性能及预测划分,2019-2024年、2024-2029年预测、2034年预测
  • 陶瓷基质复合材料(CMCs)
  • 氧化物陶瓷
  • 非氧化物陶瓷
  • 高孔隙率陶瓷
  • 全球可生物降解医用聚合物市场:依产品类型划分,实际结果与预测,2019-2024年、2024-2029年预测、2034年预测
  • 粉末
  • 涂层
  • 纤维
  • 大部分
  • 全球可生物降解医用聚合物市场:按应用、性能和预测划分,2019-2024年、2024-2029年预测、2034年预测
  • 药物输送
  • 植入
  • 缝合线
  • 其他用途
  • 全球可生物降解医用聚合物市场:依最终用户划分,实际结果与预测,2019-2024年、2024-2029年预测、2034年预测
  • 医院
  • 诊所
  • 门诊手术中心
  • 其他最终用户
  • 全球可生物降解医用聚合物市场:按聚乳酸、类型、性能和预测进行细分,2019-2024年、2024-2029年预测、2034年预测
  • 乳酸衍生的聚合物
  • 乳酸共聚物
  • 3D复合聚乳酸
  • 全球可生物降解医用聚合物市场:聚乙醇酸细分,按类型划分,实际数据和预测数据(2019-2024年、2024-2029年预测、2034年预测)。
  • 乙醇酸均聚物
  • 与其他单体的共聚物
  • 全球可生物降解医用聚合物市场:按聚己内酯、类型、性能和预测进行细分,2019-2024年、2024-2029年预测、2034年预测
  • 锁状聚己内酯
  • 支链聚己内酯
  • 交联聚己内酯
  • 全球可生物降解医用聚合物市场:聚聚羟基烷酯市场,按类型划分,实际数据和预测数据,2019-2024年、2024-2029年预测数据、2034年预测数据
  • 聚羟基丁酸酯
  • 聚羟基戊酸酯
  • 聚羟基丁酸酯 羟基戊酸酯
  • 其他聚羟基烷酯
  • 全球可生物降解医用聚合物市场:按产品、类型、性能和预测进行细分,2019-2024年、2024-2029年预测、2034年预测
  • 淀粉基聚合物
  • 纤维素基聚合物
  • 蛋白质基聚合物
  • 其他可生物降解聚合物

第七章 区域和国家分析

  • 全球可生物降解医用聚合物市场:区域分析、预测(2019-2024年、2024-2029年预测、2034年预测)
  • 全球可生物降解医用聚合物市场:国家、市场表现及预测,2019-2024年、2024-2029年预测、2034年预测

第八章 亚太市场

第九章:中国市场

第十章 印度市场

第十一章 日本市场

第十二章:澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章:德国市场

第十八章:法国市场

第十九章:义大利市场

第二十章:西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章:加拿大市场

第26章 南美洲市场

第27章:巴西市场

第28章 中东市场

第29章:非洲市场

第三十章:竞争格局与公司概况

  • 生物可降解医用聚合物市场:竞争格局
  • 生物可降解医用聚合物市场:公司概况
    • Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
    • Corbion NV Overview, Products and Services, Strategy and Financial Analysis
    • dsm-firmenich AG Overview, Products and Services, Strategy and Financial Analysis
    • Mitsui Chemicals Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Poly Medicure Limited Overview, Products and Services, Strategy and Financial Analysis

第31章:其他领先和创新企业

  • KLS Martin SE & Co. KG
  • BASF SE
  • NatureWorks LLC
  • Arkema SA
  • Eastman Chemical Company
  • Foster LLC
  • Becton, Dickinson and Company
  • Toray Industries Inc.
  • Celanese Corporation
  • Teysa Technologies Ltd
  • Kaneka Corporation
  • Arthrex Inc.
  • Ashland Inc.
  • MERIL LIFE SCIENCES INDIA PRIVATE LIMITED
  • REVA Medical LLC

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章:高潜力市场国家、细分市场与策略

  • 2029年可生物分解医用聚合物市场:提供新机会的国家
  • 2029年生物可降解医用聚合物市场:充满新机会的细分市场
  • 2029年生物可降解医用聚合物市场:成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r39942

Biodegradable medical polymers refer to a class of advanced materials that can break down into harmless byproducts within the body or environment after fulfilling their medical function. They help minimize postoperative complications, support natural healing, and remove the need for follow-up removal procedures. Their strong biocompatibility and controlled degradation behavior make them essential components in the progress of modern medical treatments.

The key product types of biodegradable medical polymers are polylactic acid, polyglycolic acid, polycaprolactone, polyhydroxyalkanoates, and others. Polylactic acid is a biodegradable thermoplastic obtained from renewable sources such as corn starch and sugarcane, and is widely applied in medical and packaging fields. The various material types include ceramic matrix composites (CMC), oxide ceramics, non-oxide ceramics, and advanced porous ceramics. The different product forms include powder, tiles, coatings, fibres, and bulk. These are used in several applications such as drug delivery, implants, sutures, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The biodegradable medical polymers market research report is one of a series of new reports from The Business Research Company that provides biodegradable medical polymers market statistics, including the biodegradable medical polymers industry global market size, regional shares, competitors with the biodegradable medical polymers market share, detailed biodegradable medical polymers market segments, market trends, and opportunities, and any further data you may need to thrive in the biodegradable medical polymers industry. This biodegradable medical polymers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biodegradable medical polymers market size has grown rapidly in recent years. It will grow from $2.38 billion in 2024 to $2.78 billion in 2025 at a compound annual growth rate (CAGR) of 16.8%. The growth in the historic period is linked to rising regulatory support for biodegradable materials, growing use of polymers in drug delivery systems, increasing focus on reducing medical waste, rising investment in biodegradable polymer manufacturing, and growing consumer preference for green healthcare solutions.

The biodegradable medical polymers market size is expected to see rapid growth in the next few years. It will grow to $5.11 billion in 2029 at a compound annual growth rate (CAGR) of 16.5%. The growth in the forecast period is expected to result from an increase in demand for eco-friendly medical devices, a rise in collaborations between polymer manufacturers and healthcare companies, an expansion in the production capacity of biodegradable polymers, greater incorporation of natural polymers in medical applications, and a rise in government incentives for sustainable medical materials. Major trends in the forecast period include advancements in biopolymer technology, progress in advanced drug delivery systems, innovation in sustainable medical devices, the integration of natural polymer blends, and improvements in wound care solutions.

The growing demand for minimally invasive procedures is expected to drive the expansion of the biodegradable medical polymers market in the coming years. Minimally invasive procedures are medical techniques that use small incisions or non-invasive methods to perform surgeries, resulting in less tissue damage, faster recovery, and less postoperative pain compared to traditional surgical approaches. The rise in these procedures is largely due to advancements in medical technology, which have led to the wider adoption of precision-driven surgical techniques across the globe. Biodegradable medical polymers play a key role in supporting minimally invasive surgeries by enabling the development of temporary implants, sutures, and drug delivery systems that naturally dissolve within the body. This reduces the need for secondary removal procedures, minimizes tissue trauma, and promotes faster recovery with fewer complications. For example, in February 2023, the American Society of Plastic Surgeons, a U.S.-based specialty organization, reported that the total number of cosmetic minimally invasive procedures rose from 23.7 million in 2022 to 25.4 million in 2023. As such, the increasing demand for minimally invasive procedures is fueling the growth of the biodegradable medical polymers market.

Leading companies in the biodegradable medical polymers market are focusing on innovations like biopolymer technology to improve the performance, biocompatibility, and sustainability of medical devices and drug delivery systems. Biopolymer technology involves the use of polymers derived from natural sources that are designed to be biodegradable and environmentally friendly. This technology is used to create sustainable materials for medical, packaging, and industrial applications, reducing dependence on synthetic plastics. For example, in November 2023, Sulzer Ltd., a Switzerland-based public company, launched CAPSUL, an end-to-end licensed technology for the continuous manufacturing of polycaprolactone (PCL), a biodegradable polyester. This technology enables the production of high-quality PCL grades at competitive rates, supporting the use of sustainable materials and improving production efficiency for medical and industrial applications.

In July 2023, Evonik Industries AG, a Germany-based chemicals company, acquired Novachem Corporation for an undisclosed amount. With this acquisition, Evonik aims to strengthen its sustainable cosmetic active ingredients portfolio by integrating Novachem's innovative, biotechnological, and eco-certified actives. This move also enhances Evonik's System Solutions offering in the personal care market across the Americas, supporting the company's transition into sustainable specialties. Novachem Corporation, based in Canada, is a manufacturer of biodegradable medical polymers.

Major companies operating in the biodegradable medical polymers market are Evonik Industries AG, Corbion N.V., dsm-firmenich AG, Mitsui Chemicals Inc., Poly Medicure Limited, KLS Martin SE & Co. KG, BASF SE, NatureWorks LLC, Arkema SA, Eastman Chemical Company, Foster LLC, Becton, Dickinson and Company, Toray Industries Inc., Celanese Corporation, Teysa Technologies Ltd, Kaneka Corporation, Arthrex Inc., Ashland Inc., MERIL LIFE SCIENCES INDIA PRIVATE LIMITED, REVA Medical LLC

North America was the largest region in the biodegradable medical polymers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in biodegradable medical polymers report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the biodegradable medical polymers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biodegradable medical polymers market consists of sales of sutures, drug delivery systems, wound dressings, orthopedic devices, dental implants, tissue engineering scaffolds, and surgical instruments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biodegradable Medical Polymers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biodegradable medical polymers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biodegradable medical polymers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biodegradable medical polymers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Polylactic Acid; Polyglycolic Acid; Polycaprolactone; Polyhydroxyalkanoates; Other Products
  • 2) By Material Type: Ceramic Matrix Composites (CMC); Oxide Ceramics; Non-Oxide Ceramics; Advanced Porous Ceramics
  • 3) By Product Form: Powder; Tiles; Coatings; Fibers; Bulk
  • 4) By Application: Drug Delivery; Implants; Sutures; Other Applications
  • Subsegments:
  • 1) By Polylactic Acid: Lactic Acid Derived Polymers; Copolymers Of Lactic Acid; Stereocomplex Polylactic Acid
  • 2) By Polyglycolic Acid: Homopolymers Of Glycolic Acid; Copolymers With Other Monomers
  • 3) By Polycaprolactone: Linear Polycaprolactone; Branched Polycaprolactone; Crosslinked Polycaprolactone
  • 4) By Polyhydroxyalkanoate: Polyhydroxybutyrate; Polyhydroxyvalerate; Polyhydroxybutyrate Hydroxyvalerate; Other Polyhydroxyalkanoates
  • 5) By Other Products: Starch Based Polymers; Cellulose Based Polymers; Protein Based Polymers; Other Biodegradable Polymers
  • Companies Mentioned: Evonik Industries AG; Corbion N.V.; dsm-firmenich AG; Mitsui Chemicals Inc.; Poly Medicure Limited; KLS Martin SE & Co. KG; BASF SE; NatureWorks LLC; Arkema SA; Eastman Chemical Company; Foster LLC; Becton, Dickinson and Company; Toray Industries Inc.; Celanese Corporation; Teysa Technologies Ltd; Kaneka Corporation; Arthrex Inc.; Ashland Inc.; MERIL LIFE SCIENCES INDIA PRIVATE LIMITED; REVA Medical LLC
  • Countries:

Table of Contents

1. Executive Summary

2. Biodegradable Medical Polymers Market Characteristics

3. Biodegradable Medical Polymers Market Trends And Strategies

4. Biodegradable Medical Polymers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Biodegradable Medical Polymers Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Biodegradable Medical Polymers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Biodegradable Medical Polymers Market Growth Rate Analysis
  • 5.4. Global Biodegradable Medical Polymers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Biodegradable Medical Polymers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Biodegradable Medical Polymers Total Addressable Market (TAM)

6. Biodegradable Medical Polymers Market Segmentation

  • 6.1. Global Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polylactic Acid
  • Polyglycolic Acid
  • Polycaprolactone
  • Polyhydroxyalkanoates
  • Other Products
  • 6.2. Global Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ceramic Matrix Composites (CMC)
  • Oxide Ceramics
  • Non-Oxide Ceramics
  • Advanced Porous Ceramics
  • 6.3. Global Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Powder
  • Tiles
  • Coatings
  • Fibers
  • Bulk
  • 6.4. Global Biodegradable Medical Polymers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Delivery
  • Implants
  • Sutures
  • Other Applications
  • 6.5. Global Biodegradable Medical Polymers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Other End-Users
  • 6.6. Global Biodegradable Medical Polymers Market, Sub-Segmentation Of Polylactic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lactic Acid Derived Polymers
  • Copolymers Of Lactic Acid
  • Stereocomplex Polylactic Acid
  • 6.7. Global Biodegradable Medical Polymers Market, Sub-Segmentation Of Polyglycolic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Homopolymers Of Glycolic Acid
  • Copolymers With Other Monomers
  • 6.8. Global Biodegradable Medical Polymers Market, Sub-Segmentation Of Polycaprolactone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Linear Polycaprolactone
  • Branched Polycaprolactone
  • Crosslinked Polycaprolactone
  • 6.9. Global Biodegradable Medical Polymers Market, Sub-Segmentation Of Polyhydroxyalkanoates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polyhydroxybutyrate
  • Polyhydroxyvalerate
  • Polyhydroxybutyrate Hydroxyvalerate
  • Other Polyhydroxyalkanoates
  • 6.10. Global Biodegradable Medical Polymers Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Starch Based Polymers
  • Cellulose Based Polymers
  • Protein Based Polymers
  • Other Biodegradable Polymers

7. Biodegradable Medical Polymers Market Regional And Country Analysis

  • 7.1. Global Biodegradable Medical Polymers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Biodegradable Medical Polymers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biodegradable Medical Polymers Market

  • 8.1. Asia-Pacific Biodegradable Medical Polymers Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biodegradable Medical Polymers Market

  • 9.1. China Biodegradable Medical Polymers Market Overview
  • 9.2. China Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biodegradable Medical Polymers Market

  • 10.1. India Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biodegradable Medical Polymers Market

  • 11.1. Japan Biodegradable Medical Polymers Market Overview
  • 11.2. Japan Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biodegradable Medical Polymers Market

  • 12.1. Australia Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biodegradable Medical Polymers Market

  • 13.1. Indonesia Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biodegradable Medical Polymers Market

  • 14.1. South Korea Biodegradable Medical Polymers Market Overview
  • 14.2. South Korea Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biodegradable Medical Polymers Market

  • 15.1. Western Europe Biodegradable Medical Polymers Market Overview
  • 15.2. Western Europe Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biodegradable Medical Polymers Market

  • 16.1. UK Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biodegradable Medical Polymers Market

  • 17.1. Germany Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biodegradable Medical Polymers Market

  • 18.1. France Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biodegradable Medical Polymers Market

  • 19.1. Italy Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biodegradable Medical Polymers Market

  • 20.1. Spain Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biodegradable Medical Polymers Market

  • 21.1. Eastern Europe Biodegradable Medical Polymers Market Overview
  • 21.2. Eastern Europe Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biodegradable Medical Polymers Market

  • 22.1. Russia Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biodegradable Medical Polymers Market

  • 23.1. North America Biodegradable Medical Polymers Market Overview
  • 23.2. North America Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biodegradable Medical Polymers Market

  • 24.1. USA Biodegradable Medical Polymers Market Overview
  • 24.2. USA Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biodegradable Medical Polymers Market

  • 25.1. Canada Biodegradable Medical Polymers Market Overview
  • 25.2. Canada Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biodegradable Medical Polymers Market

  • 26.1. South America Biodegradable Medical Polymers Market Overview
  • 26.2. South America Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biodegradable Medical Polymers Market

  • 27.1. Brazil Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biodegradable Medical Polymers Market

  • 28.1. Middle East Biodegradable Medical Polymers Market Overview
  • 28.2. Middle East Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biodegradable Medical Polymers Market

  • 29.1. Africa Biodegradable Medical Polymers Market Overview
  • 29.2. Africa Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biodegradable Medical Polymers Market Competitive Landscape And Company Profiles

  • 30.1. Biodegradable Medical Polymers Market Competitive Landscape
  • 30.2. Biodegradable Medical Polymers Market Company Profiles
    • 30.2.1. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Corbion N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. dsm-firmenich AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Mitsui Chemicals Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Poly Medicure Limited Overview, Products and Services, Strategy and Financial Analysis

31. Biodegradable Medical Polymers Market Other Major And Innovative Companies

  • 31.1. KLS Martin SE & Co. KG
  • 31.2. BASF SE
  • 31.3. NatureWorks LLC
  • 31.4. Arkema SA
  • 31.5. Eastman Chemical Company
  • 31.6. Foster LLC
  • 31.7. Becton, Dickinson and Company
  • 31.8. Toray Industries Inc.
  • 31.9. Celanese Corporation
  • 31.10. Teysa Technologies Ltd
  • 31.11. Kaneka Corporation
  • 31.12. Arthrex Inc.
  • 31.13. Ashland Inc.
  • 31.14. MERIL LIFE SCIENCES INDIA PRIVATE LIMITED
  • 31.15. REVA Medical LLC

32. Global Biodegradable Medical Polymers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biodegradable Medical Polymers Market

34. Recent Developments In The Biodegradable Medical Polymers Market

35. Biodegradable Medical Polymers Market High Potential Countries, Segments and Strategies

  • 35.1 Biodegradable Medical Polymers Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Biodegradable Medical Polymers Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Biodegradable Medical Polymers Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer